315 related articles for article (PubMed ID: 2770935)
1. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V
Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
[TBL] [Abstract][Full Text] [Related]
2. The activity of the bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in premenopausal and postmenopausal women with primary hyperparathyroidism.
Broulik PD; Stĕpán J; Pacovský V
Exp Clin Endocrinol; 1984 May; 83(3):315-9. PubMed ID: 6540700
[TBL] [Abstract][Full Text] [Related]
3. Bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in thyrotoxicosis.
Broulik PD; Stĕpán JJ; Límanová Z; Pacovský V
Endocrinol Exp; 1985 Sep; 19(3):165-9. PubMed ID: 3876205
[TBL] [Abstract][Full Text] [Related]
4. Plasma acid and alkaline phosphatase in patients with breast cancer.
Nguyen M; Bonneterre J; Hecquet B; Desoize B; Demaille A
Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338
[TBL] [Abstract][Full Text] [Related]
5. [Bone turnover markers in tumor pathology with bone involvement].
Napal Lecumberri J; Amado Señarís JA; Pesquera C; Riancho JA; González Macías J
Med Clin (Barc); 1990 Apr; 94(13):487-9. PubMed ID: 2355762
[TBL] [Abstract][Full Text] [Related]
6. Value of urinary hydroxyproline and bone isoenzyme of alkaline phosphatase in the early detection and follow-up of bone metastasis in breast cancer patients.
Frenay M; Namer M; Boublil JL; Khater R; Viot M; François E; Milano G
Bull Cancer; 1988; 75(6):533-9. PubMed ID: 3416085
[TBL] [Abstract][Full Text] [Related]
7. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.
Stĕpán JJ; Presl J; Broulík P; Pacovský V
J Clin Endocrinol Metab; 1987 May; 64(5):1079-82. PubMed ID: 3031119
[TBL] [Abstract][Full Text] [Related]
8. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
[TBL] [Abstract][Full Text] [Related]
9. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
Francini G; Gonnelli S; Petrioli R; Bruni S; Marsili S; Aquino A; Camporeale A
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):125-9. PubMed ID: 8467247
[TBL] [Abstract][Full Text] [Related]
10. [Bone isoenzyme of serum alkaline phosphatase and the excretion of hydroxyproline in bone diseases].
Stĕpán J; Pacovský V; Horn V; Silinková-Málková E; Konopásek B; Formánková J; Vokrouhlická O; Hrba J; Marek J
Vnitr Lek; 1977 Jun; 23(7):655-63. PubMed ID: 898700
[No Abstract] [Full Text] [Related]
11. Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate resistant acid phosphatase in patients on chronic maintenance hemodialysis.
Stĕpán JJ; Lachmanová J; Straková M; Pacovský V
Bone Miner; 1987 Nov; 3(2):177-83. PubMed ID: 3509796
[TBL] [Abstract][Full Text] [Related]
12. [Different behavior of bone turnover markers in endocrine (extrinsic) and structural (intrinsic) osteopathies].
Napal J; Amado JA; Riancho JA; Freijanes J; Pesquera C; González-Macías J
Med Clin (Barc); 1990 Mar; 94(8):294-8. PubMed ID: 2342391
[TBL] [Abstract][Full Text] [Related]
13. Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase.
Wolff JM; Ittel TH; Borchers H; Boekels O; Jakse G
Anticancer Res; 1999; 19(4A):2653-5. PubMed ID: 10470213
[TBL] [Abstract][Full Text] [Related]
14. A supplement to alkaline phosphatase fractionations: utilization of gamma-glutamyl transpeptidase and hydroxyproline assays.
Slaunwhite D; Tuggey RL; Reynoso G
Ann Clin Lab Sci; 1978; 8(2):117-21. PubMed ID: 25040
[TBL] [Abstract][Full Text] [Related]
15. Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms.
Radom S; Zulawski M; Golebiowska D
Pol Med J; 1972; 11(4):809-14. PubMed ID: 4342776
[No Abstract] [Full Text] [Related]
16. [Urinary hydroxyproline excretion in primary hyperparathyroidism. A comparison with other diagnostic methods].
Hartmann F
Arch Klin Med; 1968; 215(2):97-106. PubMed ID: 5718138
[No Abstract] [Full Text] [Related]
17. Serum bone alkaline phosphatase in the follow-up of skeletal metastases.
Zaninotto M; Secchiero S; Rubin D; Sciacovelli L; Trovò M; Bortolus R; Plebani M
Anticancer Res; 1995; 15(5B):2223-8. PubMed ID: 8572629
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of two serum isoenzyme phosphatases as bone metastasis markers].
Desoize B; Pourny C; Amico S; Larbre H; Jardillier JC
Bull Cancer; 1990; 77(12):1211-21. PubMed ID: 2081281
[TBL] [Abstract][Full Text] [Related]
19. Serum ostase in the follow-up of breast cancer patients.
Marchei P; Santini D; Bianco V; Chiodini S; Reale MG; Simeoni F; Marchei GG; Vecchione A
Anticancer Res; 1995; 15(5B):2217-22. PubMed ID: 8572628
[TBL] [Abstract][Full Text] [Related]
20. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
Charles P; Poser JW; Mosekilde L; Jensen FT
J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
